Home
Technology
Cardioids
Publications
Platform
Disease Models
Assays
Automation
Data Analysis
Quality Control
Case Studies
Drug Discovery
Pipeline
Cardiomyopathies
Myocardial Fibrosis
Discovery Strategy
Partnering Strategy
About
Mission
Management
Scientific Advisory
Supervisory
Partners
News
Press Releases
In The Media
Conferences
Careers
Contact
Menu
News
Press Releases
View All
HeartBeat.bio Joins Forces with Boehringer Ingelheim to Advance Gene Therapies for Inherited Heart Muscle Disorders
September 23, 2025
HeartBeat.bio and biotx.ai Sign License and Technology Access Agreement to Identify Novel Targets in Heart Failure
July 7, 2025
First multi-chamber heart organoids unravel human heart development and disease
November 29, 2023
HeartBeat.bio raises € 4.5 million in Pre-Series A financing to drive development of organoid screening platform for cardiac drug discovery
November 2, 2023
HeartBeat.bio collaborates with Boehringer Ingelheim to investigate cardiac organoids for the development of new treatments for people with heart diseases
October 5, 2022
HeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery
September 12, 2022
Press Releases
View All
HeartBeat.bio Joins Forces with Boehringer Ingelheim to Advance Gene Therapies for Inherited Heart Muscle Disorders
September 23, 2025
HeartBeat.bio and biotx.ai Sign License and Technology Access Agreement to Identify Novel Targets in Heart Failure
July 7, 2025
First multi-chamber heart organoids unravel human heart development and disease
November 29, 2023
HeartBeat.bio raises € 4.5 million in Pre-Series A financing to drive development of organoid screening platform for cardiac drug discovery
November 2, 2023
HeartBeat.bio collaborates with Boehringer Ingelheim to investigate cardiac organoids for the development of new treatments for people with heart diseases
October 5, 2022
HeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery
September 12, 2022
In The Media
View All
Galen Growth
HealthTech 250: The Most Promising Early-Stage Digital Health Ventures of 2025
March 4, 2025
Zefyron
Top 10 Early-Stage Life Sciences Startups
February 2, 2025
EU-Startups
10 Fast-Growing Austrian Startups to Watch Closely in 2025
January 2, 2025
StartUs Insights
Discover 20 Innovative Pharma Startups to Watch (2024)
July 31, 2024
Startup Stash
40 Best Austrian Startups to Watch in 2024
July 18, 2024
Die Macher
Verantwortung übernehmen, nachhaltig investieren
November 29, 2023
Molecular Devices
Molecular Devices Introduces CellXpress.ai Automated Cell Culture System, a 3D Biology Innovation Hub for Fast, Reliable Drug Discoveries
October 16, 2023
Die Presse
In Laborschalen wachsen Herzkammern im Miniformat. Die Technik bildet menschliche Organe nach und kann in der Forschung den Einsatz von Tierexperimenten verringern
October 15, 2022
Transkript
HeartBeat.bio erhöht den Kooperationstakt
October 6, 2022
Connect With Us At...
View All
Upcoming
2025
BIO-Europe 2025 Vienna
Europe’s key forum for global biotech partnering and investment.
3 Nov
5 Nov
Press Releases
In The Media
Conferences
